PDT Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,610
Closed -$329K 826
2022
Q3
$329K Buy
+6,610
New +$366K 0.05% 558
2022
Q2
Sell
-10,628
Closed -$563K 1105
2022
Q1
$563K Buy
10,628
+5,055
+91% +$292K 0.05% 547
2021
Q4
$338K Sell
5,573
-331
-6% -$19.7K 0.03% 641
2021
Q3
$331K Buy
+5,904
New +$324K 0.02% 575
2021
Q1
Sell
-8,149
Closed -$284K 855
2020
Q4
$284K Sell
8,149
-43,151
-84% -$1.53M 0.02% 556
2020
Q3
$1.87M Sell
51,300
-817
-2% -$30.4K 0.12% 222
2020
Q2
$1.96M Buy
+52,117
New +$2.08M 0.13% 213
2018
Q2
Sell
-7,316
Closed -$247K 561
2018
Q1
$247K Buy
+7,316
New +$281K 0.01% 508
2015
Q2
Sell
-29,091
Closed -$1.25M 1564
2015
Q1
$1.25M Buy
+29,091
New +$1.11M 0.03% 685
2014
Q1
Sell
-14,720
Closed -$527K 1347
2013
Q4
$527K Sell
14,720
-77,348
-84% -$2.57M 0.06% 406
2013
Q3
$2.77M Buy
92,068
+51,910
+129% +$1.7M 0.08% 364
2013
Q2
$1.17M Buy
+40,158
New +$1.13M 0.03% 756

Other funds holding PBH

PDT Partners's PBH Position: Q4 2022 in Review

PDT Partners sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 6,610 shares — an estimated $329K sold.

PDT Partners first reported a position in PBH in Q2 2013 and held it in 12 quarters. The position peaked at $2.77M in Q3 2013. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • PDT Partners reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 6,610 Prestige Consumer Healthcare shares in Q4 2022, an estimated $329K.
  • PDT Partners first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 12 quarters.
  • PDT Partners's Prestige Consumer Healthcare position peaked at $2.77M in Q3 2013.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.